Human Tissue Authority reports on the Business Impact Target

The HTA is required to assess the impact of any new regulatory activity or changes to our current activity on our licensed establishments which qualify as ‘businesses’ using an approved methodology. 

We must also publish a summary of new and updated regulatory provisions which fall under the statutory and administrative exemptions annually: these are known as Non-Qualifying Regulatory Provisions (NQRPs) and do not need to be costed.

The Business Impact Target reporting period covered 17 December 2021- 16 December 2022.

The full report and previous reports are available here.